ImmunoGen, Inc.
(NASDAQ : IMGN)

( )
Volume Open Day's Low Day's High 52 Wk Low 52 Wk High Bid Ask EPS PE Ratio Shares Market Cap Dividend Ex-Div Date Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
100% secure: your email is never shared, and you may opt out at any time.
...
Health Technology » Biotechnology
symbolcompany%chnglast%shortavg$volume
VTLVital Therapies, Inc.
1.50%13.513.3%$792.68m
AMGNAmgen Inc.
-1.31%203.311.3%$763.34m
GILDGilead Sciences, Inc.
-1.01%63.470.9%$384.47m
CELGCelgene Corporation
0.15%95.361.3%$349.24m
BIIBBiogen Inc.
-1.99%231.041.3%$303.18m
ILMNIllumina, Inc.
-1.07%285.573.5%$300.60m
VRTXVertex Pharmaceuticals Incorporated
-2.19%182.991.9%$261.18m
EXASExact Sciences Corporation
1.38%119.7924.1%$251.43m
ALXNAlexion Pharmaceuticals, Inc.
-0.84%111.732.0%$248.85m
REGNRegeneron Pharmaceuticals, Inc.
-0.74%296.162.6%$215.44m
AAgilent Technologies, Inc.
-0.75%71.211.6%$204.96m
SRPTSarepta Therapeutics, Inc.
-17.21%99.6114.7%$127.38m
INCYIncyte Corporation
-0.71%83.922.5%$99.55m
BMRNBioMarin Pharmaceutical Inc.
-1.68%76.114.3%$93.12m
GHDXGenomic Health, Inc.
0.08%74.281.8%$90.50m

Company Profile

ImmunoGen, Inc. is a biotechnology company, which engages in discovering and developing antibody-drug conjugate therapies that meaningfully improve the lives of people with cancer. Its product candidates include Mirvetuximab soravtansine, Coltuximab ravtansine, IMGN7779 and IMGN632. The company was founded in March 1981 and is headquartered in Waltham, MA.